Panel

panel colorectal cancer (KRAS, BRAF, NRAS, PIK3CA)

Turnaround time
3 weeks
Performing laboratory
Radboudumc
€ 750

panel colorectal cancer (KRAS, BRAF, NRAS, PIK3CA)



€ 750

panel colorectal cancer (KRAS, BRAF, NRAS, PIK3CA)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Predictive testing (cancer hotspot panel)

Turnaround time
3 weeks

Method

  • Targeted analysis of one or more mutations
Remarks
Targeted analysis of one or more mutations of BRAF (NM_004333.4: codons 582-615), KRAS (NM_004985.4: codons 12, 13, 59, 61, 117, 146), NRAS (NM_002524.4: codons 12, 13, 59, 61, 117, 146) and PIK3CA (NM_006218.2: codons 520-554, 1020-1069).Remark:The above mentioned genes are part of the ‘Radboud Cancer Hotspot panel’. Additional clinically relevant mutations in hotspot regions in AKT1, CTNNB1, CXCR4, EGFR, ERBB2, EZH2, GNA11, GNAQ, GNAS, H3F3A, H3F3B, HRAS, IDH1, IDH2, JAK2, KIT, MPL, MYD88, PDGFRA, SF3B1 and instability of the MSI markers BAT25, BAT26, NR21, NR24 and NR27 are also reported.

Performing laboratory: Radboudumc
Authorized material(s): FFPE




€ 750
Panel

panel gastro-intestinal stroma tumor (KIT, PDGFRA)

Turnaround time
3 weeks
Performing laboratory
Radboudumc
€ 750

panel gastro-intestinal stroma tumor (KIT, PDGFRA)



€ 750

panel gastro-intestinal stroma tumor (KIT, PDGFRA)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Predictive testing (cancer hotspot panel)

Turnaround time
3 weeks

Method

  • Targeted analysis of one or more mutations
Remarks
Targeted analysis of one or more mutations in KIT (NM_000222.2: codons 412-513, 550-591, 628-713, 799-828) and PDGFRA (NM_006206.4: codons 552-596, 632-667, 814-848).Remark:The above mentioned genes are part of the ‘Radboud Cancer Hotspot panel’. Additional clinically relevant mutations in hotspot regions in AKT1, BRAF, CTNNB1, CXCR4, EGFR, ERBB2, EZH2, GNA11, GNAQ, GNAS, H3F3A, H3F3B, HRAS, IDH1, IDH2, JAK2, KRAS, MPL, MYD88, NRAS, PIK3CA, SF3B1 and instability of the MSI markers BAT25, BAT26, NR21, NR24 and NR27 are also reported.

Performing laboratory: Radboudumc
Authorized material(s): FFPE




€ 750
Panel

panel lung cancer (KRAS, EGFR)

Turnaround time
3 weeks
Performing laboratory
Radboudumc
€ 750

panel lung cancer (KRAS, EGFR)



€ 750

panel lung cancer (KRAS, EGFR)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Predictive testing (cancer hotspot panel)

Turnaround time
3 weeks

Method

  • Targeted analysis of one or more mutations
Remarks
Targeted analysis of one or more mutations of BRAF (NM_004333.4: codons 582-615), EGFR (NM_005228.3: codons 434-499, 688-823, 849-875), KRAS (NM_004985.4: codons 12, 13, 59, 61, 117, 146), NRAS (NM_002524.4: codons 12, 13, 59, 61, 117, 146) and PIK3CA (NM_006218.2: codons 520-554, 1020-1069).Remark:The above mentioned genes are part of the ‘Radboud Cancer Hotspot panel’. Additional clinically relevant mutations in hotspot regions in AKT1, CTNNB1, CXCR4, EGFR, ERBB2, EZH2, GNA11, GNAQ, GNAS, H3F3A, H3F3B, HRAS, IDH1, IDH2, JAK2, KIT, MPL, MYD88, PDGFRA, SF3B1 and instability of the MSI markers BAT25, BAT26, NR21, NR24 and NR27 are also reported.

OMIM: 190070,1316
Performing laboratory: Radboudumc
Authorized material(s): FFPE




€ 750